1) The study aims to understand barriers to obtaining oral cancer treatment and the impact on patient experience by assessing financial toxicity, psychosocial burden, and factors associated with treatment satisfaction.
2) Preliminary findings show that while wait times and costs cause distress, receiving treatment reduces worry. Higher costs were not significantly associated with more distress. Patients waited an average of 8-9 days for medications.
3) Increased costs and wait times may be linked to greater psychosocial stress, though receiving treatment lessened worry. Further analysis of factors like memory, mood, and finances could provide more insights into adherence.
Our main involvement with your clinical research recruitment program concludes with processing the responses to your mailer. As our staff members direct the respondents to your site, you can begin conducting final interviews to complete the clinical trial recruitment process.
Satisfaction of patient’s in the dental clinics of Riyadh Dental College, Riy...iosrjce
IOSR Journal of Dental and Medical Sciences is one of the speciality Journal in Dental Science and Medical Science published by International Organization of Scientific Research (IOSR). The Journal publishes papers of the highest scientific merit and widest possible scope work in all areas related to medical and dental science. The Journal welcome review articles, leading medical and clinical research articles, technical notes, case reports and others.
Our main involvement with your clinical research recruitment program concludes with processing the responses to your mailer. As our staff members direct the respondents to your site, you can begin conducting final interviews to complete the clinical trial recruitment process.
Satisfaction of patient’s in the dental clinics of Riyadh Dental College, Riy...iosrjce
IOSR Journal of Dental and Medical Sciences is one of the speciality Journal in Dental Science and Medical Science published by International Organization of Scientific Research (IOSR). The Journal publishes papers of the highest scientific merit and widest possible scope work in all areas related to medical and dental science. The Journal welcome review articles, leading medical and clinical research articles, technical notes, case reports and others.
Clearing the Error: Patient Participation in Reducing Diagnostic ErrorJefferson Center
To generate new, patient-centered insights into diagnostic error, we convened diverse groups in public deliberation to recommend and evaluate actions that patients and/or their advocates would be willing and able to perform to improve diagnostic quality.
Weitzman 2013: State Health Policy Initiatives as Drivers for Improving Care...CHC Connecticut
Sue Birch presents on State Health Policy Initiatives as Drivers for Improving Care Outcomes: Colorado's Accountable Care Collaborative at the 2013 Weitzman Symposium
A Dartmouth Microsystem Assessment was conducted to examine a hospital unit\\’s functionality and to highlight opportunities for improvement. To enhance the gathering of data, a statistical tool was created to measure a wider sample population. The CNL student implemented a more reliable and valid data gathering system. The nurse educator asked to use the graduate student’s tool on the unit and throughout the hospital.
Stop TB Partnership focus group session 10-20-17Bruce Thomas
The Arcady Group founder, Bruce Thomas, led the Stop TB Partnership's Focus Group Workshop On Digital Adherence Technologies. At this meeting, innovators such as Everwell Health (99DOTS), Wisepill Technologies (evriMED medication monitor), Keheala (SMS-based behavioral counseling) and SureAdhere Mobile Technology (V-DOT) were connected with representatives of key NGO implementers and country programs (including Zimbabwe, Philippines, Moldova, and South Africa) to discuss opportunities for experimentation and uptake of digital adherence technologies through TB REACH Wave 6 grants. Bruce and Ram Subbaraman shared new evidence and insights about the importance of treatment adherence to avoid TB relapse.
Mosio's Clinical Trial Patient Recruitment and Retention Ebook (First Edition)Mosio
The first edition of Mosio's patient recruitment and retention ebook contains 68 tips and examples from clinical research industry professionals on ways to improve efforts to recruit, retain and engage clinical trial patients.
To get access to a free download of the 2nd Edition, visit http://www.mosio.com/prebook
For more information on how you can improve patient engagement while increasing workflow efficiencies in communicating with study participants using two-way text messaging, please visit us at http://www.mosio.com
Objective: To evaluate the utility of a targeted lecture in improving FP awareness amongst clinicians.
Design: This is a dual institution, prospective survey-based study assessing if an educational lecture can increase the likelihood of FP consideration, discussion, and referral.
Clearing the Error: Patient Participation in Reducing Diagnostic ErrorJefferson Center
To generate new, patient-centered insights into diagnostic error, we convened diverse groups in public deliberation to recommend and evaluate actions that patients and/or their advocates would be willing and able to perform to improve diagnostic quality.
Weitzman 2013: State Health Policy Initiatives as Drivers for Improving Care...CHC Connecticut
Sue Birch presents on State Health Policy Initiatives as Drivers for Improving Care Outcomes: Colorado's Accountable Care Collaborative at the 2013 Weitzman Symposium
A Dartmouth Microsystem Assessment was conducted to examine a hospital unit\\’s functionality and to highlight opportunities for improvement. To enhance the gathering of data, a statistical tool was created to measure a wider sample population. The CNL student implemented a more reliable and valid data gathering system. The nurse educator asked to use the graduate student’s tool on the unit and throughout the hospital.
Stop TB Partnership focus group session 10-20-17Bruce Thomas
The Arcady Group founder, Bruce Thomas, led the Stop TB Partnership's Focus Group Workshop On Digital Adherence Technologies. At this meeting, innovators such as Everwell Health (99DOTS), Wisepill Technologies (evriMED medication monitor), Keheala (SMS-based behavioral counseling) and SureAdhere Mobile Technology (V-DOT) were connected with representatives of key NGO implementers and country programs (including Zimbabwe, Philippines, Moldova, and South Africa) to discuss opportunities for experimentation and uptake of digital adherence technologies through TB REACH Wave 6 grants. Bruce and Ram Subbaraman shared new evidence and insights about the importance of treatment adherence to avoid TB relapse.
Mosio's Clinical Trial Patient Recruitment and Retention Ebook (First Edition)Mosio
The first edition of Mosio's patient recruitment and retention ebook contains 68 tips and examples from clinical research industry professionals on ways to improve efforts to recruit, retain and engage clinical trial patients.
To get access to a free download of the 2nd Edition, visit http://www.mosio.com/prebook
For more information on how you can improve patient engagement while increasing workflow efficiencies in communicating with study participants using two-way text messaging, please visit us at http://www.mosio.com
Objective: To evaluate the utility of a targeted lecture in improving FP awareness amongst clinicians.
Design: This is a dual institution, prospective survey-based study assessing if an educational lecture can increase the likelihood of FP consideration, discussion, and referral.
Conheça agora uma lista de sucos funcionais elaborada pelo Empório do suco. São 12 sucos funcionais para diversos sintomas e necessidades como energia para praticar atividades físicas, aliviar o stress, melhorar a digestão, etc.
In this article, Dr. Kate Matin evaluated the usefulness of an off-site dental evaluation program for bone marrow recipients. This evaluation packet enabled patients scheduled for bone marrow transplants to be evaluated by, and receive any treatment from, their own dentist rather than a dentist at the transplant center. The program generally was effective in achieving its goals and was well-accepted by patients and dentists alike.
Provider perspectives on the utility of a colorectalcancer s.docxwoodruffeloisa
Provider perspectives on the utility of a colorectal
cancer screening decision aid for facilitating shared
decision making
Paul C. Schroy III MD MPH,* Shamini Mylvaganam MPH� and Peter Davidson MD�
*Director of Clinical Research, Section of Gastroenterology, Boston Medical Center, Boston, MA, �Study Coordinator, Section of
Gastroenterology, Boston Medical Center, Boston, MA and �Clinical Director, Section of General Internal Medicine, Boston
Medical Center, Boston, MA, USA
Correspondence
Paul C. Schroy III, MD MPH
Boston Medical Center
85 E. Concord Street
Suite 7715
Boston
MA 02118
USA
E-mail: [email protected]
Accepted for publication
8 August 2011
Keywords: decision aids, informed
decision making, shared decision
making
Abstract
Background Decision aids for colorectal cancer (CRC) screening
have been shown to enable patients to identify a preferred screening
option, but the extent to which such tools facilitate shared decision
making (SDM) from the perspective of the provider is less well
established.
Objective Our goal was to elicit provider feedback regarding the
impact of a CRC screening decision aid on SDM in the primary care
setting.
Methods Cross-sectional survey.
Participants Primary care providers participating in a clinical trial
evaluating the impact of a novel CRC screening decision aid on
SDM and adherence.
Main outcomes Perceptions of the impact of the tool on decision-
making and implementation issues.
Results Twenty-nine of 42 (71%) eligible providers responded,
including 27 internists and two nurse practitioners. The majority
(>60%) felt that use of the tool complimented their usual approach,
increased patient knowledge, helped patients identify a preferred
screening option, improved the quality of decision making, saved
time and increased patients� desire to get screened. Respondents
were more neutral is their assessment of whether the tool improved
the overall quality of the patient visit or patient satisfaction. Fewer
than 50% felt that the tool would be easy to implement into their
practices or that it would be widely used by their colleagues.
Conclusion Decision aids for CRC screening can improve the
quality and efficiency of SDM from the provider perspective but
future use is likely to depend on the extent to which barriers to
implementation can be addressed.
doi: 10.1111/j.1369-7625.2011.00730.x
� 2011 John Wiley & Sons Ltd 27
Health Expectations, 17, pp.27–35
Introduction
Engaging patients to participate in the decision-
making process when confronted with prefer-
ence-sensitive choices related to cancer screening
or treatment is fundamental to the concept of
patient-centred care endorsed by the Institute of
Medicine, US Preventive Services Task Force
and the Centers for Disease Control and Pre-
vention.
1–3
Ideally, this process should occur
within the context of shared decision making
(SDM), whereby patients and their health-care
providers form a partnershi ...
Impact of health education on tuberculosis drug adherenceSkillet Tony
Adherence is defined as the extent to which patients follow the instructions they are given for prescribed treatments. Until recently, adherence expertise was hard to find, assemble and empower. The study shall solely aim at investigating the influence of patients’ health education on Tuberculosis drug adherence. It will be guided by the following specific objectives; to identify the level of adherence among TB patients at MTRH, to assess the level of patient’s health education on TB drugs, to identify barriers of TB education, to investigate the challenges facing TB patients on treatment and to determine the level of training given to health workers on TB drug adherence. These objectives will enable the researcher to elaborate more on the topic and ensure that those who read through this research shall have a better perspective on the effects of health education on tuberculosis drug adherence. It will take place between the months of July and August. The study will target 17 doctors, 119 nurses and 143 patients of Tuberculosis. The study will employ a case study research design. The case study will enable the researcher be able to collected detailed information as to the influence of patients’ health education on TB drug adherence. The study will employ purposive sampling to sample the doctors and simple random sampling to select both the nurses and the patients who will participate in the study. The researcher will use one research instrument to collect data from the respondents selected to participate in the study which is a questionnaire that will be issued to the respondents on the day of the data collection.
Research the requirements to sit for the PMP Exam (both paper and .docxronak56
Research the requirements to sit for the PMP Exam (both paper and online methods).
Write a 2 page paper. In your paper include a discussion on the following:
· The amount of experience you must have to sit for the exam
· The amount of hours of project management training you must take before you sit for the exam
· The fees required to take the exam
· Download and fill out the "PMP Credential Application - submit it with your 2 page paper in the Appendix
Include a cover sheet and 2-3 references. References should be obtained through the Grantham University online library. You may use online resources for this assignment (not Wikipedia). Please adhere to the Publication Manual of the American Psychological Association (APA), 6th ed., 2nd printing when writing and submitting assignments and papers
S224 • CID 2010:51 (Suppl 2) • Eron
S U P P L E M E N T A R T I C L E
Telemedicine: The Future of Outpatient Therapy?
Lawrence Eron
John A. Burns School of Medicine, University of Hawaii, Kaiser Moanalua Medical Center, Honolulu
Early hospital discharge of acutely infected patients to received outpatient parenteral antimicrobial therapy
has been shown to be safe and effective. However, concerns over safety, potential litigation, and anxieties of
the patient and family about not receiving professional care have limited the use of this approach. Telemedicine
may overcome these barriers by allowing health care providers to monitor and communicate with acutely
infected patients from a remote medical center via a home computer station transmitting audio, video, and
vital signs data. Potential benefits of telemedicine include significant cost savings and faster convalescence,
because patients at home may feel more comfortable and actively involved in their treatment than patients
in the hospital. Clinical studies have shown that telemedicine is safe and cost-effective, compared with hospital
treatment, in chronically ill and acutely infected patients. More studies are needed to further establish the
widespread and increasing practice of telemedicine, which may represent the future of medicine.
Early hospital discharge to use of outpatient parenteral
antimicrobial therapy (OPAT) has been shown to be
both safe and effective for the treatment of acutely in-
fected patients [1–5]. Conditions frequently treated in
this manner include community-acquired pneumonia
(CAP), skin and soft-tissue infection, urinary tract in-
fection, and bacterial endocarditis. However, OPAT
alone is not recommended for some patients with severe
illness or complications, including those who must be
monitored several times per day because of comorbid-
ities and/or low performance scores [6]. Furthermore,
the decision to discharge a patient to OPAT or to dis-
charge a patient who has been switched to oral anti-
biotics may be delayed because of persistent fever or
simply for a day of observation [4, 7, 8]. Routine in-
hospital observation after the or ...
SELF MEDICATION PRACTICES FOR ORAL HEALTH PROBLEMS AMONG DENTAL PATIENTS IN B...iosrphr_editor
Introduction: Self‑ medication is commonly practiced all over the world. Self-medication is defined as the use
of medication by a patient on his own initiative or on the advice of a pharmacist or a lay person instead of
consulting a medical practitioner. The present study was aimed to estimate the prevalence of self-medication for
oral health problems among dental patients in Bengaluru city; to identify triggering factors that could influence
self-medication practices; to identify sources of medications used; to identify sources of information about
medications used; and to identify reasons for self-medication.Study Design: A Cross sectional Study.Methods:A
survey was conducted among 175 subjects among dental patients in Bengaluru city. Data were collected
through a specially designed proforma using a closed‑ ended, self‑ administered questionnaire containing 15
questions, in five sections.
Results: The prevalence of
A thoughtful presentation on participation in clinical trials from the Thomas Jefferson University team at the 2017 CURE OM Patient & Caregiver Symposium.
Module 5 (week 9) - InterventionAs you continue to work on your .docxroushhsiu
Module 5 (week 9) - Intervention
As you continue to work on your assignment, you will be pulling in some information from your work throughout this course. For one part of this presentation, you will be identifying the current problem (or opportunity for change). This was part of your discussion in the week 2 assignment PowerPoint.
You will also propose an evidence-based intervention to address this particular problem. This intervention should be derived from the literature you have found and presented in your critical appraisal template.
As you have seen, these assignments have provided you the ability to identify a problem, develop a PCIOT question, search for evidence related to this PICOT, critically appraise the evidence for a solution to the problem, and now you will identify the solution and disseminate the results.
You are well on your way to becoming evidence-based practitioners!
Week 9!
Nice work on last week’s discussion. As you have discovered, decision aids can be very helpful when providing information for patients and families.
This week, you will continue to work on your assignment for this module. This will be an 8-9 slide PowerPoint presentation in which you will recommend an evidence-based practice change. Review the 4 articles you critiqued to determine what practice change is supported by the literature.
Some of the content for this assignment will be taken from your previous work and some will be new. This PowerPoint is a total of 8-9 slides.
Please review the full assignment details located under the learning resources for module 5.
Please let me know if you have questions
David
Provider perspectives on the utility of a colorectal
cancer screening decision aid for facilitating shared
decision making
Paul C. Schroy III MD MPH,* Shamini Mylvaganam MPH� and Peter Davidson MD�
*Director of Clinical Research, Section of Gastroenterology, Boston Medical Center, Boston, MA, �Study Coordinator, Section of
Gastroenterology, Boston Medical Center, Boston, MA and �Clinical Director, Section of General Internal Medicine, Boston
Medical Center, Boston, MA, USA
Correspondence
Paul C. Schroy III, MD MPH
Boston Medical Center
85 E. Concord Street
Suite 7715
Boston
MA 02118
USA
E-mail: [email protected]
Accepted for publication
8 August 2011
Keywords: decision aids, informed
decision making, shared decision
making
Abstract
Background Decision aids for colorectal cancer (CRC) screening
have been shown to enable patients to identify a preferred screening
option, but the extent to which such tools facilitate shared decision
making (SDM) from the perspective of the provider is less well
established.
Objective Our goal was to elicit provider feedback regarding the
impact of a CRC screening decision aid on SDM in the primary care
setting.
Methods Cross-sectional survey.
Participants Primary care providers participating in a clinical trial
evaluating the impact of a novel CRC screening d ...
1. Student Name(s): Giovanna Braganza
Primary Investigator: Supriya Mohile, MD
Title: Understanding Barriers to Obtaining Oral Cancer Treatment and Their Impact on Patient Cancer
Experience
Institution: University of Rochester Medical Center
Department: Geriatric Oncology
Understanding Barriers to Obtaining Oral Cancer Treatment and
Their Impact on Patient Cancer Experience
Introduction:
The benefits of oral oncolytics include their ease of use, convenience, and generally well-tolerated side effect
profiles as compared to traditional intravenous chemotherapy. Although the cost associated with oral
oncolytic therapy is high and growing, research into patient preferences and quality of life issues indicates
that patients prefer them to traditional intravenous chemotherapies. Studies evaluating adherence and oral
oncolytics show an association between out of pocket expense, social support, treatment adherence, and
treatment success. Currently there is little data describing the psychosocial impact of the financial burden
associated with oral cancer medication and its influence on patient satisfaction and medication adherence.
Objective:
Through this study we hope to:
1. Assess how financial health impacts patient satisfaction and distress during oral oncolytic treatment.
2. Measure the psychosocial burden of financial toxicity in patient undergoing oral cancer treatment.
3. Identify patient characteristics or other factors associated with patterns of treatment satisfaction.
4. Document total time and resources used by healthcare professionals in assisting patients obtain oral
cancer therapy.
Background:
Oral oncolytics are a relatively new form of anti-cancer therapy that account for roughly 25% of the oncology
drug market.1
As insurance providers devise methods of controlling their use and cost, patients are placed at
higher risk of out of pocket spending and consequently poor adherence and compliance to their cancer
treatment plans.2
Although the cost associated with cancer care and oral oncotic therapy is high and growing,
research into patient preferences and quality of life issue indicates that patients prefer oral chemotherapies
as opposed to traditional intravenous chemotherapies.3
The benefits of oral oncolytics include their ease of use, convenience, and generally well-tolerated side effect
profiles. It is important to note that because of the increased independence associated with oral oncolytic
therapy, patients require a greater level of responsibility to properly and safely administer their own oral
cancer treatments. Studies evaluating adherence and oral oncolytics show an association between
2. adherence, cost, and treatment success.4
Studies have also shown that factors such as related side effects,
out of pocket expense, and social support affect patient adherence.5
Methods:
The study population includes patients 18 years and older with solid tumor malignancy, other than breast
cancer, who are prescribed an oral oncolytic at the University of Rochester Medical Center. Study participants
are followed from the time oral cancer medication is prescribed until approximately 3 months after receipt of
medication. Details are shown in figures 1 and 2 below.
Week 1 2 4 2 4 6 8 10
Pt identifiedbyPharm/RN Staff
• Email notificationprompts enrollmentin
Study
• Complete Consent, Blessed, Call back
Form
• Give Baseline and Cover letter,and
PMRS
Day 1
D-1 2wk Visit
Pharm/GerioncStaff
• Collect complete
PMRS
• Give F/U Survery 1
w/CL
2 wks F/U
Pharm/GerioncStaff
• Collect f/u survey 1
• Give f/u survey 2 w/
CL
4-8 Wks F/U
Pharm/GerioncStaff
• Collect f/u survey 1
• Give Park voucher
10-14Wk F/U
Wkly Until
Meds
Received
Phone Survey
Every 2-4 WKS for
up to 14 WKS
Pill CountForm
Completed
Pill Count
12
Oral Chemo Timeline
GU Tumors
Reminderphone call
• Baseline survey and
Cover letter
D-1 4-8 wk Visit
Reminderphone call
• F/U survey 1
D-1 10-14wkVisit
Reminderphone call
• F/U survey 2
RX Received
Figure 1: Oral chemo study time line for GU Tumors
RX Received
Week
1
2 4 2 4 6 8
Pt identified by Pharm/RN Staff
• Email notificationprompts
enrollment in Study
• Complete Consent,Blessed, Call
back Form
• Give Baseline and Cover letter, and
PMRS
Day 1
D-1 2wk Visit
Pharm/Gerionc Staff
• Collect Baseline & complete
PMRS
• Give F/U Survery 1 w/CL
2 wks F/U
Pharm/Gerionc Staff
• Collect f/u survey 1
• Give Parking Voucher;
Study complete
4-8 Wks F/U
Wkly Until
Meds
Received
Phone Survey
Oral Chemo Timeline
All Other Tumors Reminder phone call
• Baseline survey and Cover letter
D-1 4-8 wk Visit
Reminder phone call
• F/U survey 1
Figure 2: Oral chemo study time line for All other non-GU Tumors.
As illustrated in the figures, validated patient reported outcomes tools and interviews are used to measure
the psychosocial impact of prescription wait time and to quantify financial burden, document side effect
profile, and describe patient experience while taking medication. Evaluation of medication adherence for
patients with genitourinary malignancy was done by utilizing pill counts and a comprehensive review of
medication regiment at monthly intervals.
3. Tables 1 and 2: Patient recorded outcome tools used to measure the psychosocial impact of prescription wait
time and to quantify financial burden, document side effect profile, and describe patient experience while taking
medication
Documentation of health care professional workload in assisting patients to receive oral cancer treatment is
quantified using a questionnaire.
Bivariate and multivariable analyses will be incorporated to evaluate potential associations among clinical
factors, patient reports, financial burdens, and psychosocial impacts of out of pocket costs, medication
adherence, and certain patterns for prescription wait times or certain treatment recommendations.
Results and Conclusions:
We anticipated that patients experience significant costs associated with taking oral oncolytic medications.
We also expected to find that increased cost sharing and wait time for delivery of medication would result in
higher psychosocial stress. Preliminary data however suggested that once medication is received, there is a
significant decline in worry among study participants (average baseline worry scale score of 5.2 compared to
an average follow-up worry scale score of 2.8, where 10=extremely worried) (Table 3).
Table 3. Study participant characteristicsCharacteristics Frequency
Urologic Malignancy N = 17
Non-Urologic Malignancy N= 21
Average Age 62
Work Status
Employed 9
Unemployed 21
Healthcare Provider Subjects N = 20
Baseline Worry Scale 5.2 (0-10)
PMRS Worry Scale 4.3 (0-10)
Follow-Up Worry Scale 2.8 (0-10)
4. Preliminary findings examining personal characteristics and distress display:
1. More patients with >80k reported no distress vs. distress. This association is not statistically
significant but a larger sample size might be warranted to determine correlations.
Household Income Distress
No
Distress
$0- $19,000 1 0
$20,000- $39,000 4 1
$40,000 - $59,000 4 0
$60,000 - $80,000 1 0
> $80,000 5 9
Prefer not to
answer
2 3
Total 17 13
(n=30 at baseline)
Insurance Type Mean Distress
Baseline Survey
Mean Distress PMRS
Survey
Medicare 4 5.3
Private 3.8 3.8
Grants & Patient Care Funds 3.8 4.6
Unknown/Unable to Extract 6 3
(n=26 at baseline, n=25 PMRS survey)
2. In a cohort of 26 patients, individuals with Urologic malignancies and Non-Urologic cancer paid on
average between $299-599 for oral oncolytic medications between the years of 2014 - 2016. Costs
reported were out of pocket expenses taken before insurance reimbursements and external grants
were applied.
0
1
2
3
4
5
6
7
8
$0 -$199 $200 -
$499
$500 -
$999
$1000 -
$4999
$5000 -
$9999
Frequency
Out of Pocket Expense for Oral Oncolytics
Non- GU
GU
5. 3. Patients at the Wilmot Cancer Center facility waited 0 – 37 days between the date they were
prescribed an oral oncolytic and the date the oral oncolytic medication was received. Through the
Post-Medication Receipt Survey and additional Follow-Up Surveys, patients self-reported a high
average frustration experienced while waiting for the oral oncolytics. However, patients reported
ease in finding resources to fund oral oncolytics guided by their healthcare team.
Type of Cancer
Days Waiting
for Oral
Oncolytic
Difficulty
obtaining
Oral
Oncolytic
Frustration
waiting for
Oral Oncolytic
Difficulty finding
resources to pay
for pills
Urologic Malignancy (N=17) 9.4 (0-37) 4.2 (0-10) 6.1 (0-10) 2.2
Non-Urologic Malignancy (N=21) 8.2 (0-37) 4.6 (0-10) 7.1 (0-10) 2.5
4. Data from post-medication receipt surveys revealed that increased cost sharing and wait time for
delivery of medication may be associated with higher psychosocial stress. A higher average score of
depression was reported for patients with urologic malignancies. While this study collected data on
memory, distress and depression, further analysis could be aimed to better profile risk factors,
memory loss and the cognitive side effects of oral oncolytics. Future research should further evaluate
factors associated with poor medication adherence in patients taking oral cancer medications such
as memory, mood, fatigue, and financial stress.
Type of
Cancer
Geriatric
Depression
Score(0-15)
Distress
Score(0-10)
Blessed
Score (28-0)
Satisfaction
with Cancer
Care ( 0-5)
Rating
of
Facility
( 0-5)
GU 3.8 4.6 1.9 4.4 4.4
Non-GU 2.3 4.6 2.9 4.73 4.8